Investors Sell Waters (WAT) on Strength (WAT)

Traders sold shares of Waters Co. (NYSE:WAT) on strength during trading on Wednesday. $12.00 million flowed into the stock on the tick-up and $30.37 million flowed out of the stock on the tick-down, for a money net flow of $18.37 million out of the stock. Of all equities tracked, Waters had the 31st highest net out-flow for the day. Waters traded up $0.36 for the day and closed at $204.23

WAT has been the subject of several research reports. Deutsche Bank increased their price objective on Waters from $199.00 to $200.00 and gave the stock a “hold” rating in a research report on Wednesday, October 25th. Bank of America increased their price objective on Waters from $192.00 to $202.00 and gave the stock a “neutral” rating in a research report on Friday, November 10th. Barclays increased their price objective on Waters from $188.00 to $193.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 25th. Cowen reiterated a “hold” rating and set a $190.00 price objective on shares of Waters in a research report on Friday, November 3rd. Finally, Zacks Investment Research cut Waters from a “buy” rating to a “hold” rating in a research report on Thursday, October 26th. Twelve analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. Waters presently has an average rating of “Hold” and a consensus price target of $203.75.

The company has a current ratio of 2.10, a quick ratio of 1.97 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $16,398.12, a PE ratio of 1,074.95, a PEG ratio of 2.47 and a beta of 0.88.

Waters (NYSE:WAT) last released its earnings results on Tuesday, January 23rd. The medical instruments supplier reported $2.51 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.44 by $0.07. Waters had a return on equity of 24.70% and a net margin of 0.88%. The firm had revenue of $687.28 million for the quarter, compared to analysts’ expectations of $671.98 million. During the same quarter in the previous year, the business posted $2.21 earnings per share. The business’s revenue for the quarter was up 9.3% on a year-over-year basis. sell-side analysts expect that Waters Co. will post 8.16 earnings per share for the current year.

In other news, SVP David Terricciano sold 21,997 shares of Waters stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $197.52, for a total transaction of $4,344,847.44. Following the sale, the senior vice president now directly owns 9,173 shares of the company’s stock, valued at $1,811,850.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Elizabeth B. Rae sold 28,400 shares of Waters stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $219.01, for a total value of $6,219,884.00. Following the sale, the senior vice president now directly owns 13,443 shares in the company, valued at $2,944,151.43. The disclosure for this sale can be found here. Insiders have sold 121,289 shares of company stock worth $25,383,542 over the last three months. Insiders own 5.07% of the company’s stock.

Hedge funds have recently made changes to their positions in the company. Banco de Sabadell S.A acquired a new position in shares of Waters in the fourth quarter worth approximately $193,000. Brown Advisory Securities LLC acquired a new position in shares of Waters in the fourth quarter worth approximately $202,000. Advisory Services Network LLC lifted its stake in shares of Waters by 6.0% in the second quarter. Advisory Services Network LLC now owns 1,145 shares of the medical instruments supplier’s stock worth $210,000 after acquiring an additional 65 shares during the period. Checchi Capital Advisers LLC acquired a new position in shares of Waters in the fourth quarter worth approximately $210,000. Finally, Trust Co. of Virginia VA acquired a new position in shares of Waters in the fourth quarter worth approximately $213,000. 93.36% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Investors Sell Waters (WAT) on Strength (WAT)” was first published by Week Herald and is the sole property of of Week Herald. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright and trademark law. The original version of this piece of content can be viewed at https://weekherald.com/2018/02/21/investors-sell-waters-wat-on-strength-wat.html.

Waters Company Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply